Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 8333 (118th)

BIOSECURE Act

referredUnited States· United States Congress· EN

Introduced

10 May 2024

Last action

10 September 2024 · Introduced

Status

Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Sponsors

Rep. Wenstrup, Brad R. [R-OH-2], Rep. Krishnamoorthi, Raja [D-IL-8], Rep. Moolenaar, John R. [R-MI-2], Rep. Eshoo, Anna G. [D-CA-18], Rep. Dunn, Neal P. [R-FL-2], Rep. Moulton, Seth [D-MA-6], Rep. Stefanik, Elise M. [R-NY-21], Rep. Davis, Donald G. [D-NC-1], Rep. Hinson, Ashley [R-IA-2], Sen. Slotkin, Elissa [D-MI], Rep. Bice, Stephanie I. [R-OK-5], Rep. Gottheimer, Josh [D-NJ-5], Rep. Suozzi, Thomas R. [D-NY-3], Rep. LaHood, Darin [R-IL-16], Rep. Green, Mark E. [R-TN-7]

Subjects

Healthcare, Defence, Budget

Source updated

27 May 2025

Healthcare · Defence · Budget

Official sourceDownload fileView documentsShare

Summary

BIOSECURE Act This bill prohibits entities that receive federal funds from using biotechnology that is from a company associated with a foreign adversary. Specifically, federal agencies and recipients of federal funds (e.g., grantees) may not procure or use any biotechnology equipment or service that is from a biotechnology company of concern and may not contract with any entities that do so. A  biotechnology company of concern is an entity that is under the control of a foreign adversary and that poses a risk to national security based on its research or multiomic data collection (e.g., collection of genomic information). The Office of Management and Budget (OMB) must, in coordination with the Department of Defense (DOD) and other specified agencies, develop a list of prohibited companies; the list must include five particular companies, as specified in the bill. OMB and DOD may approve waivers of these restrictions on an as-needed basis, which are valid for up to one year and may be extended once for an additional 180 days. In addition, the Office of the Director of National Intelligence must report on the national security risks posed by (1) multiomic data collection by foreign adversaries in connection with biotechnology equipment or services, and (2) biotechnology companies that have such data.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 10 May 2024

    Introduced

    Referred to the Committee on Oversight and Accountability, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 10 May 2024

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 10 May 2024

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 15 May 2024

    Vote

    Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 1.

    Source: Committee

  5. 15 May 2024

    Committee

    Committee Consideration and Mark-up Session Held

    Source: Committee

  6. 9 September 2024

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

  7. 9 September 2024

    Vote

    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)

    Source: Floor

  8. 9 September 2024

    Vote

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)

    Source: Floor

  9. 9 September 2024

    Vote

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

    Source: Floor

  10. 9 September 2024

    Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 8333.

    Source: Floor

  11. 9 September 2024

    Floor

    Considered under suspension of the rules. (consideration: CR H5051-5058)

    Source: Floor

  12. 9 September 2024

    Floor

    Mr. Comer moved to suspend the rules and pass the bill, as amended.

    Source: Floor

  13. 10 September 2024

    Introduced

    Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

    Source: IntroReferral

Votes

9 September 2024 · passed · On Motion to Suspend the Rules and Pass, as Amended · Passed · Official source

Yes 306 · No 81 · Abstain — · Absent/not voting 44

Showing the first 4 recorded positions. Vote totals above are complete.

Versions

Documents

7 official files

Referred in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Referred in Senate (text)

    Referred in Senate · EN · 10 September 2024

    ViewDownloadOpen at official source

  • Referred in Senate (PDF)

    Referred in Senate · EN · 10 September 2024

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Engrossed in House (text)

    Engrossed in House · EN · 9 September 2024

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Engrossed in House (PDF)

    Engrossed in House · EN · 9 September 2024

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 10 May 2024

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (PDF)

    Introduced in House · EN · 10 May 2024

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 10 May 2024

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.